TY - JOUR
T1 - Clinical and Hormonal Profiles Correlate with Molecular Characteristics in Patients with 11β-Hydroxylase Deficiency
AU - Yildiz, Melek
AU - Isik, Emregul
AU - Abali, Zehra Yavas
AU - Keskin, Mehmet
AU - Ozbek, Mehmet Nuri
AU - Bas, Firdevs
AU - Ucakturk, Seyit Ahmet
AU - Buyukinan, Muammer
AU - Onal, Hasan
AU - Kara, Cengiz
AU - Storbeck, Karl Heinz
AU - Darendeliler, Feyza
AU - Cayir, Atilla
AU - Unal, Edip
AU - Anik, Ahmet
AU - Demirbilek, Huseyin
AU - Cetin, Tugba
AU - Dursun, Fatma
AU - Catli, Gonul
AU - Turan, Serap
AU - Falhammar, Henrik
AU - Baris, Tugba
AU - Yaman, Ali
AU - Haklar, Goncagul
AU - Bereket, Abdullah
AU - Guran, Tulay
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Background: Given the rarity of 11β-hydroxylase deficiency (11βOHD), there is a paucity of data about the differences in clinical and biochemical characteristics of classic (C-11βOHD) and nonclassic 11βOHD (NC-11βOHD). Objective: To characterize a multicenter pediatric cohort with 11βOHD. Method: The clinical and biochemical characteristics were retrospectively retrieved. CYP11B1 gene sequencing was performed. Seventeen plasma steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. Results: 102 patients (C-11βOHD, n=92; NC-11βOHD, n=10) from 76 families (46,XX; n=53) had biallelic CYP11B1 mutations (novel 9 out of 30). Five 46,XX patients (10%) were raised as males. Nineteen patients (19%) had initially been misdiagnosed with 21-hydroxylase deficiency. Female adult height was 152 cm [-1.85 SD score (SDS)] and male 160.4 cm (-2.56 SDS).None of the NC-11βOHD girls had ambiguous genitalia (C-11βOHD 100%), and none of the NC-11βOHD patients were hypertensive (C-11βOHD 50%). Compared to NC-11βOHD, C-11βOHD patients were diagnosed earlier (1.33 vs 6.9 years; P<0.0001), had higher bone age-to-chronological age (P=0.04) and lower adult height (-2.46 vs-1.32 SDS; P=0.05). The concentrations of 11-oxygenated androgens and 21-deoxycortisol were low in all patients. The baseline ACTH and stimulated cortisol were normal in NC-11βOHD. Baseline cortisol; cortisone; 11-deoxycortisol; 11-deoxycorticosterone and corticosterone concentrations; and 11-deoxycortisol/cortisol, 11-deoxycorticosterone/cortisol, and androstenedione/cortisol ratios were higher in C-11βOHD than NC-11βOHD patients (P<0.05). The 11-deoxycortisol/cortisol ratio >2.2, <1.5, and <0.1 had 100% specificity to segregate C-11βOHD, NC-11βOHD, and control groups. Conclusion: NC-11βOHD can escape from clinical attention due to relatively mild clinical presentation. However, steroid profiles enable the diagnosis, differential diagnosis, and subtyping of 11βOHD.
AB - Background: Given the rarity of 11β-hydroxylase deficiency (11βOHD), there is a paucity of data about the differences in clinical and biochemical characteristics of classic (C-11βOHD) and nonclassic 11βOHD (NC-11βOHD). Objective: To characterize a multicenter pediatric cohort with 11βOHD. Method: The clinical and biochemical characteristics were retrospectively retrieved. CYP11B1 gene sequencing was performed. Seventeen plasma steroids were quantified by liquid chromatography-mass spectrometry and compared to that of controls. Results: 102 patients (C-11βOHD, n=92; NC-11βOHD, n=10) from 76 families (46,XX; n=53) had biallelic CYP11B1 mutations (novel 9 out of 30). Five 46,XX patients (10%) were raised as males. Nineteen patients (19%) had initially been misdiagnosed with 21-hydroxylase deficiency. Female adult height was 152 cm [-1.85 SD score (SDS)] and male 160.4 cm (-2.56 SDS).None of the NC-11βOHD girls had ambiguous genitalia (C-11βOHD 100%), and none of the NC-11βOHD patients were hypertensive (C-11βOHD 50%). Compared to NC-11βOHD, C-11βOHD patients were diagnosed earlier (1.33 vs 6.9 years; P<0.0001), had higher bone age-to-chronological age (P=0.04) and lower adult height (-2.46 vs-1.32 SDS; P=0.05). The concentrations of 11-oxygenated androgens and 21-deoxycortisol were low in all patients. The baseline ACTH and stimulated cortisol were normal in NC-11βOHD. Baseline cortisol; cortisone; 11-deoxycortisol; 11-deoxycorticosterone and corticosterone concentrations; and 11-deoxycortisol/cortisol, 11-deoxycorticosterone/cortisol, and androstenedione/cortisol ratios were higher in C-11βOHD than NC-11βOHD patients (P<0.05). The 11-deoxycortisol/cortisol ratio >2.2, <1.5, and <0.1 had 100% specificity to segregate C-11βOHD, NC-11βOHD, and control groups. Conclusion: NC-11βOHD can escape from clinical attention due to relatively mild clinical presentation. However, steroid profiles enable the diagnosis, differential diagnosis, and subtyping of 11βOHD.
KW - 11-oxygenated androgens
KW - CYP11B1
KW - adrenal insufficiency
KW - androgen excess
KW - children
KW - congenital adrenal hyperplasia
KW - steroid profiling
UR - https://www.scopus.com/pages/publications/85114356813
U2 - 10.1210/clinem/dgab225
DO - 10.1210/clinem/dgab225
M3 - Article
C2 - 33830237
AN - SCOPUS:85114356813
SN - 0021-972X
VL - 106
SP - E3714-E3724
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 9
ER -